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Abstract: Eupatorium cannabinum L. (Asteraceae) has been used for a long time for medicinal purposes due to its various pharmacological
effects and richness in active compounds such as phenolics, sesquiterpenes, pyrrolizidine alkaloids, and polysaccharides. Despite the
high content of compounds that have important roles in medicinal plants, there are still limited literature data regarding this valuable
species. The plant was fractioned using chloroform (EC) and distilled water (EA) and HPLC analysis revealed the presence of eupatorin,
eupatilin, and quercetin in EC and caffeic acid and rutin in EA. The antiproliferative potential on BT-20, HepG2, Caco-2, and Jurkat
cancer cell lines was assessed by MTS test. Jurkat cells were more sensitive to both extracts (IC50 of 7.35 ± 0.35 for EC and 13.77 ±
2.16 µg/mL for EA), while the other lines were susceptible only to EC (IC50 88.27 ± 1.34 on Caco-2 cells and over 100 µg/mL on BT20 and HepG2 cells) after 24 h of exposure. In an LPS-induced damage mouse model of endotoxemia, we showed that preventive
administration increases the survival times of mice and leads to inhibition of proinflammatory cytokines. Both polar and nonpolar
compounds are involved in exerting these effects, but further analytical studies are needed to identify the key responsible compounds
and their biochemical pathways.
Key words: Hemp-agrimony, antiinflammatory, methoxyflavones, endotoxemia

1. Introduction
The genus Eupatorium belongs to the family Asteraceae
and comprises about 60 species that have mostly been used
in folk medicine or as ornamental plants. Among species,
many possess a wide range of pharmacological activities,
such as cytotoxic, antifungal, insecticidal, antibacterial,
antiinflammatory, and antinociceptive activities (Liu et al.,
2015). For some species like E. perfoliatum, E. chinense, E.
arnottianum, and E. lindleyanum, these diverse therapeutic
indications are correlated with specific active compounds
such as phenolics, sesquiterpenes, pyrrolizidine alkaloids,
and polysaccharides.
Although Eupatorium cannabinum L., commonly
known as hemp-agrimony, has been used for a long
time for medicinal purposes, few scientific studies have
occurred. In this regard, some studies have been conducted
for chemical analysis, focusing especially on essential oil
constituents (Senatore et al., 2001; Paolini et al., 2005;
* Correspondence: alicearmatu@yahoo.com

Mirza et al., 2006), and some identified compounds of
other classes such as polysaccharides (Vollmar et al.,
1986), pyrrolizidine alkaloids (Hendriks et al., 1983, 1987),
polyphenolcarboxylic acids (Fraisse et al., 2011; Ionita et
al., 2013), and flavones (Elema et al., 1989).
Considering the biological activity of E. cannabinum,
however, few studies are available related to antitumor
(Chen et al., 2014; Ribeiro-Varandas et al., 2014),
antiinflammatory (Chen et al., 2011), hepatoprotective
(Lexa et al., 1989; Clavin et al., 2007; Judzentiene et al.,
2016), and immunomodulatory (Vollmar et al., 1986;
Clavin et al., 2007) properties of crude extracts or isolated
compounds.
The ethanolic extract was more studied, and reports
showed both cytotoxic and antiinflammatory activity.
Ribeiro-Varandas et al. (2014) showed that E. cannabinum
had cytotoxic activity on HT29 cancer cells and synergistic
effects with doxorubicin. Similarly, the extract modulates
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proinflammatory functions of stimulated neutrophils
such as reactive oxygen species, interleukin 8 (IL8), tumor necrosis factor alpha (TNF-α) production/
release, and expression of adhesion molecules CD11b/
CD18. The major sesquiterpene lactone isolated from
this species, eupatoriopicrin, inhibits (IC50 < 1 µM) IL-8
and TNF-α release by human neutrophils in response to
lipopolysaccharides (LPS) (Michalak et al., 2017).
In this research, the antiproliferative activity of polar
and nonpolar extracts of E. cannabinum was examined in
vitro against BT-20, HepG2, Caco-2, and Jurkat cancer cell
lines. Moreover, in vitro and in vivo survival tests were also
carried out to investigate the protective influence towards
endotoxins by assessment of LPS-stimulated macrophage
viability and a mouse model of endotoxemia. A possible
correlation of biological activity with chemical content of
E. cannabinum extracts is discussed.
2. Materials and methods
2.1. Plant material
E. cannabinum L. was cultivated under ecological
conditions by a commercial grower (S.C. Dacia Plant
S.R.L., Bod, Romania) in 2016, dried, and ground to a fine
powder. A voucher specimen (EC160701) was deposited
with the manufacturer.
2.2. Preparation of extracts
The chloroform extract (EC) was prepared by soaking
150 g of the plant in 1500 mL of chloroform (1:10 w/v)
for 2 days at room temperature, followed by filtration. The
crude extract was concentrated under reduced pressure
(72–74 mmHg) and the resultant product (11.03 g) was
dissolved in 50% ethyl alcohol to obtain a stock solution
of 10 mg/mL.
The aqueous extract (EA) was prepared by boiling the
raw material that resulted from chloroform extraction
with 1500 mL of distilled water under reflux for 30 min,
followed by filtration. The crude extract was concentrated
under reduced pressure (72–74 mmHg) and the resultant
product (43.08 g) was dissolved in 50% ethyl alcohol to
obtain a stock solution of 10 mg/mL.
Both EC and EA extracts were further diluted according
to each assay protocol.
2.3. HPLC analysis
Quantitative HPLC analysis of the main components was
performed on an HPLC ELITE LaChrom system with a
DAD detector and a Luna C18(2) column (250 × 4.6 mm,
5 µm) at 23 °C, using a gradient elution. Separation of
polyphenols was performed using a mobile phase consisting
of an A solution (water acidified with phosphoric acid, pH
3.0) and a B solution (acetonitrile) at an initial flow rate of
1 mL/min with an injection of 10 µL. For determination of
ecdysone content the abovementioned column was used
and the mobile phase consisted of 20% acetonitrile for
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isocratic elution at an initial flow rate of 1.5 mL/min with
an injection of 20 µL.
Reference substances were purchased as follows:
quercetin, rutin, and caffeic acid were from Sigma Aldrich
(Germany) and eupatorin, eupatilin, and β-ecdysone were
from PhytoLab (Germany).
2.4. Cell lines and culture conditions
The following cell lines were purchased from the
American Type Culture Collection (ATCC, USA) and
used: NR8383 (normal rat alveolar macrophages), BT20 (human mammary gland/ breast carcinoma), HepG2
(human hepatocellular carcinoma), Caco-2 (human
colorectal adenocarcinoma), and Jurkat (leukemia
peripheral blood lymphocytes). Dulbecco’s modified
Eagle’s medium (DMEM), Dulbecco’s modified Eagle’s
medium F12 (DMEM-F12), Roswell Park Memorial
Institute (RPMI) medium, fetal bovine serum (FBS),
penicillin-streptomycin, Dulbecco’s phosphate-buffered
saline (DPBS), and trypsin-EDTA solution were from
Life Technologies (USA). For cell viability assay, 96-well
microplates from Corning (USA) were used. Dimethyl
sulfoxide (DMSO) and bacterial lipopolysaccharide
(E. coli LPS K-235) were obtained from Sigma Aldrich
(Germany). Cells were cultured in EMEM (BT-20, Caco2), DMEM (HepG2), DMEM-F12 (NR8383), or RPMI
1640 (Jurkat) medium supplemented with 10% (Jurkat,
Caco-2, HepG2), 15% (NR8383), or 20% (BT-20) FBS
and penicillin-streptomycin (1%, 100 units/mL) and were
maintained at 37 °C in a humidified atmosphere with 5%
CO2. Media were replaced two to three times per week.
Adherent cells were washed with DPBS (pH 7.0) and then
treated with trypsin (0.05%)-EDTA (0.002%), collected,
and centrifuged. Cells were aliquoted and 15 to 20 mL
were transferred to 75-mL flasks, after which they were
passaged every 5 days. Once a week, the nonadherent
cell line (Jurkat) was established by centrifugation and
subsequent resuspension at 1 × 106 viable cells/mL.
2.5. Survival of LPS-stimulated macrophages
An assay was used to assess the potential cytotoxic effect
of the extracts on a normal rat macrophage cell line
(NR8383) and also to evaluate their influence in the case
of LPS stimulation. A total of 1 × 104 cells/well were seeded
into 96-well plates and were allowed to settle for 24 h. The
cells were then treated with several dilutions of extracts
ranging from 25 to 150 µg/mL. Each concentration/assay
was performed three times. A mixture of DMSO and
water (extract solvent) was diluted with culture media in
the same way as samples and served as a negative control.
As positive control, levamisole (100 µg/mL) was used. The
cells were incubated with the treatments for 24 h, after
which 20 µL of MTS (5 mg/mL, CellTiter 96-Aqueous One
Solution Cell Proliferation Assay, Promega) was added
and further incubated for 4 h at 37 °C. The absorbance was
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measured at 492 nm with an LKB Chameleon microplate
reader. Cell viability was expressed as a percentage of live
treated cells compared with live control cells.
For evaluation of survival of LPS-stimulated
macrophages, cells were treated with serum-free media
supplemented with several dilutions of extracts (25–150 µg/
mL) in the presence of LPS (10 µg/mL). LPS alone served
as a negative control. After 18 h of incubation, the cultures
were also subjected to MTS assay as described above.
2.6. Antiproliferative activity on cancer cells
An assay was used to assess the effect of the extracts on the
survival of human cancer cell lines. A total of 1 × 103 (BT-20,
Caco-2, HepG2) or 2.5 × 103 (Jurkat) cells/well were seeded
into 96-well plates and were allowed to settle for 24 h. The
cells were then treated with several dilutions of extracts
ranging from 6.25 to 250 µg/mL. Each concentration/
assay was performed three times. A mixture of DMSO and
water (extract solvent) was diluted with culture media in
the same way as samples and served as a negative control.
As positive controls, several concentrations (6.25–100 µg/
mL) of 5-fluorouracil were used. The cells were incubated
with the treatments for 24–48 h, after which 20 µL of
MTS (5 mg/mL, CellTiter 96-Aqueous One Solution Cell
Proliferation Assay, Promega) was added and further
incubated for 4 h at 37 °C. The absorbance was measured
at 492 nm with an LKB Chameleon microplate reader. Cell
viability was expressed as a percentage of live treated cells
compared with live control cells.
2.7. Animal model of endotoxemia and survival test
All animal studies were approved by the Ethics Committee
of the National Institute of Chemical-Pharmaceutical
Research and Development. Briefly, NMRI mice (males,
6 weeks old, 20–25 g) purchased from the Cantacuzino
Institute (Bucharest, Romania) were housed in a pathogenfree environment. Sepsis/lethal endotoxemia was induced
by administration of bacterial endotoxin by intraperitoneal
(IP) injection (20 mg/kg). At –48, –24, and +0.5 h post
sepsis animals were administered IP saline (0.2 mL/20 g
mouse) or EC/EA at indicated doses, and animal survival
was monitored for up to 10 days. Mice were randomly
assigned to the following groups: injection of saline (group

I), injection of LPS (20 mg/kg) (group II), simultaneous
IP injection of LPS (20 mg/kg) plus EC (250, 500, or 875
mg/kg) (groups III–V) or respectively EA (250, 500, or
875 mg/kg) (groups VI–VIII), or injection of levamisole
(10 mL/kg) (group IX) for 3 days. Ten days after the last
administration, animals were euthanized and blood was
collected and analyzed.
In parallel similar experiments, mice were euthanized
18 h after LPS challenge to collect blood and assayed for
plasma levels of cytokines.
2.8. Cytokine assays
The TNF-α, IL-1β, and IL-6 concentrations in the
plasma samples were determined by enzyme-linked
immunosorbent assay (ELISA) using commercial kits
specific for mice (Novex-Life Technologies, USA) and
following the manufacturer’s instructions. The results were
recorded in terms of the optical density measured at 450
nm with an LKB Chameleon multiplate reader.
2.9. Statistical analysis
For the statistical analysis, the paired Student t-test was
used. The results were expressed as means ± SD of at least
three independent experiments. P < 0.05 was statistically
significant. All analyses were performed with GraphPad
Prism (version 7.03; GraphPad Software Inc., USA).
3. Results and discussions
3.1. HPLC analysis
Consecutive extraction of E. cannabinum raw material
with chloroform and water, respectively, was conducted for
separation of two corresponding fractions, EC and EA, with
different profiles, correlated to the compounds’ polarity.
As reference substances we selected ubiquitous phenolic
compounds (rutin, caffeic acid, etc.) and methoxylated
flavones mainly found in Asteraceae species. All selected
compounds exhibit strong cytotoxic or antiinflammatory
activity comparatively based on the used concentration.
While EA lacks methoxylated flavones but contains high
amounts of caffeic acid and rutin, EC is characterized by
the presence of nonpolar compounds such as eupatorin,
eupatilin, and quercetin. As for β-ecdysone, it is almost
equally distributed in both fractions (Table).

Table. The main compounds identified in EC and EA extracts by HPLC.*

Sample

Reference compound (mg/100 g extract)
β-Ecdysone

Eupatorin

Eupatilin

Quercetin

Rutin

Caffeic acid

EC

10.05 ± 0.91

2.89 ± 1.2

12.14 ± 1.8

25.13 ± 3.4

-

-

EA

11.78 ± 2.8

-

-

1.61 ± 0.8

455.42 ± 0.9

178.86 ± 2.7

*Values are means ± standard deviations of triplicate samples.
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To ensure that the extracts were not toxic to
normal cells, cell viability after treatment with various
concentrations of EC and EA extracts was determined
using a rat alveolar macrophage cell culture. The NR8383
cell viability decreased with increasing concentration of
the extracts from 25 to 150 µg/mL (Figure 1). Generally,
concentrations of 125 µg/mL yielded cell viability higher
than 50%, whereas at 100 µg/mL it was higher than 80% in
the case of both extracts.
In LPS-stimulated macrophages, both extracts failed to
induce a protective effect. Comparing to LPS, for treated
cells, the viability of cells treated simultaneously with
extracts and LPS was lower. This could be explained by the
fact that additional cytotoxic effects were induced by the
extracts in LPS-stimulated cells (Figure 2).
3.2. Assessment of in vitro antiproliferative effect on
tumor cells
We conducted a screening of several tumor cell lines’
viability after exposure to increasing concentrations of E.
cannabinum polar and nonpolar extracts (6.25–250 µg/
mL) for 24 and 48 h, as described in Section 2. The EC
extract exhibited a dose-dependent inhibitory effect on
all cell lines, with IC50 of 7.35 µg/mL against Jurkat cells
(Figure 3), 88.27 µg/mL against Caco-2 (Figure 4) cells,
and over 100 µg/mL against HepG2 (Figure 5) and BT20 cells (Figure 6) after 24 h of incubation. Jurkat cells
were more susceptible to the inhibitory action of both
extracts. EA had an effect only on this line, with an IC50
of 13.77 µg/mL. The chloroform extract was more active
than the aqueous one, which implies that active nonpolar
principles are responsible for the antiproliferative activity
in E. cannabinum. Regarding the dynamics of inhibition,

Figure 1. The percentage viability of NR8383 cells treated with
various concentrations of EC and EA for 24 h. The viability of
cells was determined by MTS assay. Values represent mean ± SD
(n = 3, *P < 0.05, **P < 0.01, ***P < 0.001).
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Figure 2. The percentage viability of NR8383 cells untreated
(negative control), treated with only 10 ng/mL LPS (positive
control), and treated with various concentrations of EC and EA
in the presence of 10 µg/mL LPS for 18 h. The viability of cells was
determined by MTS assay. Values represent mean ± SD (n = 3, *P
< 0.05, **P < 0.01, ***P < 0.001).

it was noted that after 48 h both extracts were acting
differently. While EC inhibitory action was limited and
after 48 h cells exhibited a recovery of proliferative activity
(increased viability of Jurkat cells with 33.51% at maximum
concentration of the extract compared to proliferation
rate registered at 24 h), EA maintained its inhibitory
action, decreasing cell viability by 14.63% (HepG2) and
24.21% (Jurkat) compared to the viability rate at 24 h. The
same prolonged inhibitory effect was also shown by the
reference compound, 5-FU (decreased viability of HepG2
cells by 46.63% and of Jurkat cells by 23.22% at maximum
concentration tested compared to proliferation rate
registered at 24 h).
Although the antiproliferative effect of phenolic
compounds such as caffeic acid and rutin is well
documented, in this study the EA extract containing
high amounts of the two mentioned compounds failed to
exert certain inhibitory action on the tumor cells tested.
Previously, Elema et al. (1989) showed that the cytotoxic
activity of E. cannabinum flavones is considerably lower
compared to sesquiterpene lactones and consequently
these compounds do not significantly contribute to the
cytotoxic properties of this species. Castillo et al. (2015)
worked on E. illitum and showed that flavonoids exhibit
only moderate to low antiproliferative activities on
human cancer cell lines A549 (lung), HBL-100 (breast),
HeLa (cervix), SW1573 (lung), and T-47D (breast).
Water-soluble compounds exhibit low antiproliferative
effects towards HeLa, Eahy 926, and L929 cell lines
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Figure 3. Effect of EC and EA extracts on viability of Jurkat cells after 24 h (a) and 48 h
(b) of exposure. Values represent mean ± SD (n = 3, *P < 0.05, **P < 0.01, ***P < 0.001).

compared to nonpolar or ethanol soluble compounds
such as sesquiterpene lactones, as reported previously by
Habtemariam and Macpherson (2000). In this regard, the
E. cannabinum ethanolic extract had cytotoxic activity
on HT29 cancer cells, leading to mitotic disruption and
nonapoptotic cell death without severe induction of
DNA damage, with synergistic effects with doxorubicin
(Ribeiro-Varandas et al., 2014).
In addition, some methoxyflavones, including those
found in our extracts, play key roles in exerting several
pharmacological activities, including antiproliferative and
cytotoxic effects. For instance, eupatilin (5,7-dihydroxy3′,4′,6-trimethoxyflavone)
exhibits
antioxidant,
antiinflammatory, antiallergic, and neuroprotective

activities (Du et al., 2017); induces apoptosis in both
human promyelocytic leukemia HL-60 cells (Seo and
Surh, 2001) and human gastric cancer AGS cells (Kim
et al., 2005); and inhibits LPS-induced expression of
inflammatory mediators (iNOS, TNF-α, IL-1β, IL-6, COX2, and MCP-1) in macrophages by suppression of NF-κB
activation (Choi et al., 2011). Eupatorin (3′,5-dihydroxy4′,6,7-trimethoxyflavone) is a potent antiproliferative
agent against several cancer cell lines such as organotypic
3D prostate cancer (Salmela et al., 2012), human cervical
adenocarcinoma (HeLa), human gastric adenocarcinoma
(MK-1), murine melanoma (B16F10), murine colon
carcinoma (26-L5), or human breast cancer cell line
(MDA-MB-468), but it has no cytostatic effects in the
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Figure 4. Effect of EC and EA extracts on viability of Caco-2 cells after 24 h of exposure. Values represent mean ± SD (n = 3,*P < 0.05, **P
< 0.01, ***P < 0.001).

Figure 5. Effect of EC and EA extracts on viability of HepG2 cells after 24 h (a) and 48 h (b) of exposure. Values represent mean ± SD
(n = 3, *P < 0.05, **P < 0.01, ***P < 0.001).
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Figure 6. Effect of EC and EA extracts on viability of BT-20 cells after 24 h of exposure.
Values represent mean ± SD (n = 3, *P < 0.05, **P < 0.01, ***P < 0.001).

normal human breast cell line (MCF-10A) (Dolečková
et al., 2012). The outcome of this study proves that these
compounds might be responsible for the antiproliferative
effect, since the EC extract, the most specifically active
one, contains the abovementioned methoxyflavones.
3.3. Effect of E. cannabinum extracts on survival times in
a mouse model of endotoxemia
LPS has been used in various studies because of its ability
to induce a rapid response at the host level in a dosedependent manner. LPS induces cytokine secretion
(TNF, IL-1, IL-6) mediated by TLR-4 receptors. The
highest rates of activated leukocytes were observed upon
the administration of the largest LPS doses (20 mg/kg)
(Burkovskiy et al., 2013). However, in the previous in
vitro assay, assessment of cell viability by the MTS test
showed that both extracts failed to protect LPS-stimulated
macrophages. Though LPS stimulation involves other
cells, the effects of EC and EA on the survival times in
a mouse model of endotoxemia were evaluated and are
shown in Figures 7 and 8. The extracts were administrated
as chemopreventive agents at 48 and 24 h before LPS
challenge and at 30 min after it to induce protection
against septic shock.
Survival rates were similar for minimum and
maximum doses tested for both extracts. The first 24 h
were obviously dose-dependent for both extracts and
a difference can be noted between them: at 500 mg/kg
extract concentration, EC induced 100% protection, while
EA decreased survival rate up to 80%. For all extracts
and LPS, the maximum decrease in survival rate was
registered at 24 h and it remained constant throughout the

monitoring period. Levamisole, the reference compound,
induced 100% protection.
3.4. Effects of E. cannabinum extracts on cytokine
production in a mouse model of endotoxemia
TNF-α, IL-1β, and IL-6 are key proinflammatory cytokines
induced by LPS. IL-6 is a soluble mediator with a
pleiotropic effect on inflammation, immune response, and
hematopoiesis. An immediate and transient expression of
IL-6 is generated in response to environmental stress factors
such as infections and tissue injuries (Tanaka et al., 2014).
The effect of EC and EA on the dynamics of IL-6 in
plasma of NMRI mice is shown in Figure 9. Maximum
doses tested of EC and EA (500 and 875 mg/kg) decreased
IL-6 levels at 18 h after LPS challenge (P < 0.01), with higher
impact of EA (87% decrease compared to LPS alone). At the
minimum dose tested, 250 mg/kg, EC protected it by 40%
while EA only 16.8%. The reference compound, levamisole
(10 mg/kg), showed 98% inhibitory effect on IL-6 level (P <
0.001) compared to LPS alone.
As for the inhibitory capacity of Eupatorium extracts on
IL-1β levels, the EA at high concentrations (500 and 875
mg/kg, P < 0.01) decreased its expression by 60%, similarly
to levamisole (Figure 10). EC protected it only at the
maximum concentration by 21.1%.
Administration of EA, especially at high doses, had an
important inhibitory effect on TNF-α expression compared
to normal saline (P < 0.01) (Figure 11). EA induced a
significant protection of 77%–100% at all concentrations
tested, while EC induced a decrease of TNF-α level of
45.84%–100%. Levamisole decreased TNF-α expression up
to 30%.
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Figure 7. Effect of EC on survival times in mouse model of endotoxemia. Data represent the mean ± SD, n = 10. Group
I - Mice injected with IP saline, group II - injection with LPS (20 mg/kg), groups III–V - simultaneous IP injection of
LPS (20 mg/kg) plus EC (250–875 mg/kg).

Figure 8. Effect of EA on survival times in mouse model of endotoxemia. Data represent the mean ± SD, n = 10. Group
I - Mice injected with IP saline, group II - injection with LPS (20 mg/kg), groups III–V - simultaneous IP injection of LPS
(20 mg/kg) plus EC (250–875 mg/kg).

Significant (for IL-1α and IL-1β) and moderate (for
TNF-α) downregulation of cytokines after LPS challenge
was reported for methanol, ethanol, and dichloromethane
extracts of E. perfoliatum having eupafolin and a dimeric
guaianolide as probable responsible compounds (Maas et
al., 2011), the sesquiterpene fraction of E. lindleyanum (Chu
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et al., 2016), and 2-hydroxyeupatolide, a sesquiterpene
lactone, widely found in the genus Eupatorium (Ke et al.,
2017).
IL-6, TNF-α, and IL-1β are under transcription control
of NF-kB, which is activated by LPS and plays significant
roles in proliferation, cell survival, and inflammation.
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Figure 9. Effect of EC and EA treatment on IL-6 expression in mouse model
of endotoxemia 18 h after LPS challenge. Values represent mean ± SD (n =
5, *P < 0.05, **P < 0.01, ***P < 0.001). The results are representative of three
independent experiments.

Figure 10. Effect of EC and EA treatment on IL-1β expression in mouse model of
endotoxemia 18 h after LPS challenge. Values represent mean ± SD (n = 5, *P < 0.05, **P
< 0.01, ***P < 0.001). The results are representative of three independent experiments.

In this study, EA had a greater inhibitory effect on
proinflammatory cytokine expression than EC; it might be
suggested that the hydrosoluble compounds are involved
in inflammation-activation pathways.
3.5. Conclusions
This study aimed to prove some of the beneficial effects
of E. cannabinum species, widely used based on its
therapeutic properties. Testing the influence of EC and

EA extracts against proliferation of BT-20, HepG2, Caco2, and Jurkat cancer cell lines could not highlight the
responsible compounds for this effect. While the nonpolar
extract, rich in methoxylated flavones, had a moderate
cytotoxic effect after 24 h of exposure on most of the cell
lines tested, the polar extract, with a high content of caffeic
acid and rutin, exhibited a certain antiproliferative effect
mostly after 48 h of exposure.
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The effects of two E. cannabinum extracts with
different solubilities were tested also on an endotoxininduced mouse model of endotoxemia. Although the
LPS-stimulated rat alveolar macrophages did not show
any protective effect in vitro, the results of in vivo studies
demonstrated that preventive administration of EC and EA
increased the survival times of mice and led to inhibition
of proinflammatory cytokines (TNFα, IL-1β, and IL-6).
This study confirmed the potential cytotoxicity of E.
cannabinum as well as the protective effect against bacterial
endotoxins and proinflammatory factors. Both polar and
nonpolar compounds are involved in exerting these effects,
but further analytical studies are needed to identify the key
responsible compounds and the biochemical pathways for
their action.
Figure 11. Effect of EC and EA treatment on TNF-α expression
in mouse model of endotoxemia 18 h after LPS challenge. Values
represent mean ± SD (n = 5, *P < 0.05, **P < 0.01, ***P < 0.001).
The results are representative of three independent experiments.
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